HOME > 研究紹介 > 発表論文 > 2024年


発表論文 - 2024年

  1. Toma T, Miyakawa N, Arakaki Y, Watanabe T, Nakahara R, Ali TFS, Biswas T, Todaka M, Kondo T, Fujita M, Otsuka M, Araki E, and Tateishi H.
    An anti-fibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models.
    Diabetologia, in press.
  2. Radwan MO, Sakai S, Hassan AN, Uesugi M, Sakamoto M, Toma T, Abourehab MAS, Badran MM, Tateishi H, Nishimura N, Otsuka M, and Fujita M.
    Discovery of cytotoxic truncated vitamin D derivatives against both bortezomib‐sensitive and bortezomib‐resistant multiple myeloma phenotypes.
    Medicinal Chemistry Research, in press.
  3. Sever B, Otsuka M, Fujita M, and Ciftci H.
    A review of FDA-approved anti-HIV-1 drugs, anti-Gag compounds, and potential strategies for HIV-1 eradication.
    International Journal of Molecular Sciences 25: 3659, 2024.
  4. Nakamura T, Ohyama C, Sakamoto M, Toma T, Tateishi H, Matsuo M, Chirifu M, Ikemizu S, Morioka H, Fujita M, Inoue J, and Yamagata Y.
    TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA.
    Proceedings of the National Academy of Sciences of the United States of America 121: e2318794121, 2024.
  5. Badran MM, Abbas SH, Tateishi H, Maemoto Y, Toma T, Ito A, Fujita M, Otsuka M, Abdel-Aziz M, and Radwan MO.
    Ligand-based design and synthesis of new trityl histamine and trityl cysteamine derivatives as SIRT2 inhibitors for cancer therapy.
    European Journal of Medicinal Chemistry 269: 116302, 2024.
  6. Toma T, Miyakawa N, Tateishi M, Todaka M, Kondo T, Fujita M, Otsuka M, Araki E, and Tateishi H.
    An ADAM17 selective inhibitor promotes glucose uptake by activating AMPK.
    Journal of Pharmacological Sciences 154: 37-46, 2024.
  7. Tateishi H, Chinen T, Fukuda R, Radwan MO, Shimagaki K, Koga R, Masuda T, Okamoto Y, Sakamoto A, Misumi S, Otsuka M, Fujita M, and Anraku K.
    HIV-1 Gag MA domain binds to cardiolipin in a binding mode distinct from virus assemble mediator PI(4,5)P2.
    Chemical Biology & Drug Design 103: e14401, 2024.